"harmful and Potentially harmful Constituents" in Tobacco Products as Used in Section 904(e) of the Federal Food, Drug, and Cosmetic act (Revised)
Policy
FDa (2016)
Meetings with Industry and Investigators on the Research and Development of Tobacco Products
Policy
FDa (2016)
Premarket Tobacco Product applications for Electronic Nicotine Delivery Systems - Guidance for Industry
Policy
FDa (2016)
Premarket Tobacco Product applications for Electronic Nicotine Delivery Systems - Guidance for Industry.
Policy
FDa (2019)
human abuse liability assessment of e-cigarettes: Why, what and how?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Fearon (2022)
Nicotine pharmacokinetics of electronic cigarettes: a review of the literature
Nonclinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2018)
a randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2022)
Popcorn worker's lung: In vitro exposure to diacetyl, an ingredient in microwave popcorn butter flavoring, increases reactivity to methacholine
Nonclinical
Respiratory Toxicity
In Vitro
Fedan (2006)
E-Cigarettes-a review of the evidence-harm versus harm reduction.
Population Clinical
Population Health Impact
Feeney (2022)
Use of tobacco cessation aids and likelihood of smoking cessation: A French population-based study.
Population Clinical
Cessation
Tobacco
Fekom (2022)